Qvella Corporation

About:

Qvella is a molecular diagnostics company with the goal of dramatically reducing time to results in bacteriology.

Website: http://www.qvella.com/

Twitter/X: qvellacorp

Top Investors: RA Capital Management, Sands Capital Ventures, Kensington Capital Partners Limited, Hatteras Venture Partners, bioMerieux

Description:

Qvella is a molecular diagnostics company founded in 2009 by a group of scientists and engineers with the primary goal of dramatically reducing time to results in microbiology. This objective, widely recognized as highly desirable, has proved elusive yet holds the promise of revolutionizing how medicine is practiced by offering actionable results in clinically relevant time frames to improve patient outcomes and save lives. Qvella's Field Activated Sample Treatment (FAST™) technology utilizes a novel electrical lysing and sample treatment technique we call e-lysis™; enabling direct and fully-automated rapid detection of infectious agents from unenriched biological samples.